These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 26203926)

  • 21. GPU-accelerated nonparametric kinetic analysis of DCE-MRI data from glioblastoma patients treated with bevacizumab.
    Hsu YH; Ferl GZ; Ng CM
    Magn Reson Imaging; 2013 May; 31(4):618-23. PubMed ID: 23200680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of relative permeability and relative cerebral blood volume in high-grade cerebral neoplasms.
    Provenzale JM; York G; Moya MG; Parks L; Choma M; Kealey S; Cole P; Serajuddin H
    AJR Am J Roentgenol; 2006 Oct; 187(4):1036-42. PubMed ID: 16985154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-related Perfusion Changes in White Matter Adjacent to Brain Tumors: Pharmacodynamic Analysis of Dynamic 3T Magnetic Resonance Imaging.
    Tupý R; Mírka H; Mraček J; Přibáň V; Hes O; Vokurka S; Ferda J
    Anticancer Res; 2018 Jul; 38(7):4149-4152. PubMed ID: 29970543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic contrast-enhanced computed tomography as a potential biomarker in patients with metastatic renal cell carcinoma: preliminary results from the Danish Renal Cancer Group Study-1.
    Mains JR; Donskov F; Pedersen EM; Madsen HH; Rasmussen F
    Invest Radiol; 2014 Sep; 49(9):601-7. PubMed ID: 24691140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intratumor distribution and test-retest comparisons of physiological parameters quantified by dynamic contrast-enhanced MRI in rat U251 glioma.
    Aryal MP; Nagaraja TN; Brown SL; Lu M; Bagher-Ebadian H; Ding G; Panda S; Keenan K; Cabral G; Mikkelsen T; Ewing JR
    NMR Biomed; 2014 Oct; 27(10):1230-8. PubMed ID: 25125367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.
    Pinker K; Bogner W; Baltzer P; Gruber S; Bickel H; Brueck B; Trattnig S; Weber M; Dubsky P; Bago-Horvath Z; Bartsch R; Helbich TH
    Invest Radiol; 2014 Jun; 49(6):421-30. PubMed ID: 24566292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic contrast-enhanced magnetic resonance imaging may act as a biomarker for vascular damage in normal appearing brain tissue after radiotherapy in patients with glioblastoma.
    Fahlström M; Fransson S; Blomquist E; Nyholm T; Larsson EM
    Acta Radiol Open; 2018 Nov; 7(11):2058460118808811. PubMed ID: 30542625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab.
    Wen Q; Jalilian L; Lupo JM; Molinaro AM; Chang SM; Clarke J; Prados M; Nelson SJ
    J Neurooncol; 2015 Jan; 121(2):331-9. PubMed ID: 25351579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
    Thomsen H; Steffensen E; Larsson EM
    Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognosis prediction of measurable enhancing lesion after completion of standard concomitant chemoradiotherapy and adjuvant temozolomide in glioblastoma patients: application of dynamic susceptibility contrast perfusion and diffusion-weighted imaging.
    Kim JH; Choi SH; Ryoo I; Yun TJ; Kim TM; Lee SH; Park CK; Kim JH; Sohn CH; Park SH; Kim IH
    PLoS One; 2014; 9(11):e113587. PubMed ID: 25419975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative evaluation of 3-dimensional pseudocontinuous arterial spin labeling with dynamic contrast-enhanced perfusion magnetic resonance imaging in grading of human glioma.
    Roy B; Awasthi R; Bindal A; Sahoo P; Kumar R; Behari S; Ojha BK; Husain N; Pandey CM; Rathore RK; Gupta RK
    J Comput Assist Tomogr; 2013; 37(3):321-6. PubMed ID: 23673999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts.
    Pöschinger T; Renner A; Eisa F; Dobosz M; Strobel S; Weber TG; Brauweiler R; Kalender WA; Scheuer W
    Invest Radiol; 2014 Jul; 49(7):445-56. PubMed ID: 24598441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absolute quantification of regional renal blood flow in swine by dynamic contrast-enhanced magnetic resonance imaging using a blood pool contrast agent.
    Lüdemann L; Nafz B; Elsner F; Grosse-Siestrup C; Meissler M; Kaufels N; Rehbein H; Persson PB; Michaely HJ; Lengsfeld P; Voth M; Gutberlet M
    Invest Radiol; 2009 Mar; 44(3):125-34. PubMed ID: 19151609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma.
    Hahn OM; Yang C; Medved M; Karczmar G; Kistner E; Karrison T; Manchen E; Mitchell M; Ratain MJ; Stadler WM
    J Clin Oncol; 2008 Oct; 26(28):4572-8. PubMed ID: 18824708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
    Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
    Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of methods for determining vascular permeability and blood volume in human gliomas.
    Harrer JU; Parker GJ; Haroon HA; Buckley DL; Embelton K; Roberts C; Balériaux D; Jackson A
    J Magn Reson Imaging; 2004 Nov; 20(5):748-57. PubMed ID: 15503330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Glioblastomas and Brain Metastases using Dynamic Contrast-Enhanced Perfusion MRI.
    Jung BC; Arevalo-Perez J; Lyo JK; Holodny AI; Karimi S; Young RJ; Peck KK
    J Neuroimaging; 2016; 26(2):240-6. PubMed ID: 26235208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Automated voxel-based analysis of volumetric dynamic contrast-enhanced CT data improves measurement of serial changes in tumor vascular biomarkers.
    Coolens C; Driscoll B; Chung C; Shek T; Gorjizadeh A; Ménard C; Jaffray D
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):48-57. PubMed ID: 25446606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between intravoxel incoherent motion diffusion-weighted MRI and dynamic contrast-enhanced MRI in tissue perfusion of cervical cancers.
    Lee EY; Hui ES; Chan KK; Tse KY; Kwong WK; Chang TY; Chan Q; Khong PL
    J Magn Reson Imaging; 2015 Aug; 42(2):454-9. PubMed ID: 25413245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypercellularity Components of Glioblastoma Identified by High b-Value Diffusion-Weighted Imaging.
    Pramanik PP; Parmar HA; Mammoser AG; Junck LR; Kim MM; Tsien CI; Lawrence TS; Cao Y
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):811-9. PubMed ID: 26104935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.